Stock Events

Biosenic 

€0.02
2
+€0+0% Friday 07:04

Statistics

Day High
0.02
Day Low
0.02
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
3.41M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-0.15
-0.1
-0.05
0
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BT1.F. It's not an investment recommendation.

About

Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa studies for the treatment of delayed-union fractures and lumbar spinal fusion. The company is also developing JTA-004, an intra-articular injectable, which is in phase III development for the treatment of osteoarthritic pain in the knee. Bone Therapeutics SA has collaborations with Cerhum, 3D-Side, mSKIL, and IREC to develop personalized, tissue engineered bone implants. The company was incorporated in 2006 and is based in Gosselies, Belgium.
Show more...
CEO
Dr. Miguel Forte
Employees
30
Country
BE
ISIN
BE0974280126
WKN
000A14NHV

Listings